Medtronic plc (MDT) stock
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/303% above fair value
$100.72−1.60 (-1.56%)
Close on Nov 18, 2026Market cap $128.84BP/E 24.7Yield 2.82%
Medtronic revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Medtronic's revenue for the twelve months ending Jul 31, 2026 was $37.54B, up 9.8% year over year. For fiscal 2026 it was $36.36B, up 8.4% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $36.36B in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $36.36B | +8.4% |
| FY2025 | Apr 25, 2025 | $33.54B | +3.6% |
| FY2024 | Apr 26, 2024 | $32.36B | +3.6% |
| FY2023 | Apr 28, 2023 | $31.23B | -1.4% |
| FY2022 | Apr 29, 2022 | $31.69B | +5.2% |
| FY2021 | Apr 30, 2021 | $30.12B | +4.2% |
| FY2020 | Apr 24, 2020 | $28.91B | -5.4% |
| FY2019 | Apr 26, 2019 | $30.56B | +2.0% |
| FY2018 | Apr 27, 2018 | $29.95B | +0.8% |
| FY2017 | Apr 28, 2017 | $29.71B | +3.0% |
| FY2016 | Apr 29, 2016 | $28.83B | +42.3% |
| FY2015 | Apr 24, 2015 | $20.26B | +19.1% |
| FY2014 | Apr 25, 2014 | $17.01B | +2.5% |
| FY2013 | Apr 26, 2013 | $16.59B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $9.76B | +13.7% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $9.81B | +9.9% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $9.02B | +8.7% |
| Q2 FY2026CQ3 2025 | Oct 24, 2025 | $8.96B | +6.6% |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $8.58B | +8.4% |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $8.93B | +3.9% |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $8.29B | +2.5% |
| Q2 FY2025CQ3 2024 | Oct 25, 2024 | $8.40B | +5.2% |
| Q1 FY2025CQ2 2024 | Jul 26, 2024 | $7.92B | +2.8% |
| Q4 FY2024CQ1 2024 | Apr 26, 2024 | $8.59B | +0.5% |
| Q3 FY2024CQ4 2023 | Jan 26, 2024 | $8.09B | +4.7% |
| Q2 FY2024CQ3 2023 | Oct 27, 2023 | $7.98B | +5.3% |
| Q1 FY2024CQ2 2023 | Jul 28, 2023 | $7.70B | +4.5% |
| Q4 FY2023CQ1 2023 | Apr 28, 2023 | $8.55B | +5.6% |
| Q3 FY2023CQ4 2022 | Jan 27, 2023 | $7.73B | -0.5% |
| Q2 FY2023CQ3 2022 | Oct 28, 2022 | $7.59B | -3.3% |
| Q1 FY2023CQ2 2022 | Jul 29, 2022 | $7.37B | -7.7% |
| Q4 FY2022CQ1 2022 | Apr 29, 2022 | $8.09B | -1.2% |
| Q3 FY2022CQ4 2021 | Jan 28, 2022 | $7.76B | -0.2% |
| Q2 FY2022CQ3 2021 | Oct 29, 2021 | $7.85B | +2.6% |
| Q1 FY2022CQ2 2021 | Jul 30, 2021 | $7.99B | +22.7% |
| Q4 FY2021CQ1 2021 | Apr 30, 2021 | $8.19B | +36.5% |
| Q3 FY2021CQ4 2020 | Jan 29, 2021 | $7.78B | +0.8% |
| Q2 FY2021CQ3 2020 | Oct 30, 2020 | $7.65B | -0.8% |
| Q1 FY2021CQ2 2020 | Jul 31, 2020 | $6.51B | -13.2% |
| Q4 FY2020CQ1 2020 | Apr 24, 2020 | $6.00B | -26.4% |
| Q3 FY2020CQ4 2019 | Jan 24, 2020 | $7.72B | +2.3% |
| Q2 FY2020CQ3 2019 | Oct 25, 2019 | $7.71B | +3.0% |
| Q1 FY2020CQ2 2019 | Jul 26, 2019 | $7.49B | +1.5% |
| Q4 FY2019CQ1 2019 | Apr 26, 2019 | $8.15B | +0.0% |
| Q3 FY2019CQ4 2018 | Jan 25, 2019 | $7.55B | +2.4% |
| Q2 FY2019CQ3 2018 | Oct 26, 2018 | $7.48B | +6.1% |
| Q1 FY2019CQ2 2018 | Jul 27, 2018 | $7.38B | -0.1% |
| Q4 FY2018CQ1 2018 | Apr 27, 2018 | $8.14B | +2.9% |
| Q3 FY2018CQ4 2017 | Jan 26, 2018 | $7.37B | +1.2% |
| Q2 FY2018CQ3 2017 | Oct 27, 2017 | $7.05B | -4.0% |
| Q1 FY2018CQ2 2017 | Jul 28, 2017 | $7.39B | – |
| Q4 FY2017CQ1 2017 | Apr 28, 2017 | $7.92B | – |
| Q3 FY2017CQ4 2016 | Jan 27, 2017 | $7.28B | – |
| Q2 FY2017CQ3 2016 | Oct 28, 2016 | $7.35B | – |
See a number that looks wrong?